Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 07/01/2009 - (DGNews)
    Certain Biomarkers Have Limitations in Predicting Cardiovascular Events - (DGNews)
    Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study - (BMJ)
    TopAbstracts in Hypertension 06/24/2009 - (DGNews)
    TopAbstracts in Hypertension 06/17/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    Thrombotic Thrombocytopenic Purpura: The Masquerader
    Innovative Strategies in Cardiometabolic Risk Reduction
    Diuretics for the Treatment of Hypertension
    Managing Hypertension: Addressing the Challenges in Special Populations

    Webcasts/CME archive

     Recent cases - Hypertension
      Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
      Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
      Giant Right Coronary Artery Aneurysm: Case Report and Literature Review
      Normalization of Systemic Arterial Hypertension Following Removal of Posterior Fossa Hemangioblastoma: A Case Report
      Headache and Seizure on Postpartum Day 5: Late Postpartum Eclampsia

      Cases archive
        




      my personal edition > hypertension > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Nightime Melatonin Supplementation May Be Useful in the Treatment of Essential Hypertension

      A DGReview of :"Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension"
      Hypertension

      02/04/2004
      By Deanna M Green, PhD


      Supplemental melatonin, taken daily for 3 weeks at bedtime, decreases nocturnal blood pressure and improves sleep quality in men with essential hypertension, according to a randomised, double-blind, placebo-controlled, crossover trial.

      The biological clock is responsible for adaptation to rest and activity through regulation of morning increases in cortisol, heart rate, and glucose, and evening increases in melatonin levels.

      Studies have suggested that patients with high blood pressure have anatomical disturbances of their biological clocks and often have suppressed night-time melatonin levels. These effects may increase the risk of cardiovascular incidents in the early morning.

      Frank A.J.L. Scheer, PhD, at the Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States, and colleagues evaluated whether repeated bedtime melatonin reduces ambulatory blood pressure in patients with essential hypertension. The study was conducted at the Netherlands Institute for Brain Research in Amsterdam.

      The study included 16 men with mild to moderate untreated, uncomplicated, essential hypertension. Patients were initially randomised to receive either oral melatonin (2.5 mg/day) or placebo 1 hour before bedtime for 1 day. Patients were subsequently given melatonin or placebo for 3 weeks and then crossed-over to the opposite treatment arm for 3 additional weeks.

      Nocturnal systolic and diastolic blood pressure decreased significantly after 3 weeks of bedtime melatonin therapy, without changing heart rate. Specifically, mean sleep systolic blood pressure decreased by 6 mm Hg and mean sleep diastolic blood pressure decreased by 4 mm Hg. Notably, melatonin did not affect daytime systolic and diastolic blood pressure as compared to placebo.

      Moreover, a 15 to 25% enhancement of the day-night rhythm amplitude of systolic and diastolic blood pressure was observed with 3 weeks of melatonin therapy as compared with placebo.

      Repeated melatonin significantly increased sleep efficiency from 80% to 85% and increased actual sleep time from 5.6 to 6.1 hours. Melatonin therapy also reduced sleep latency from 33 to 22 minutes.

      One-day melatonin therapy had no effect on systolic and diastolic blood pressure while asleep or awake. Moreover, acute melatonin did not significantly influence sleep efficiency, actual sleep time, or sleep latency.

      The authors conclude that "repeated, but not single, bedtime melatonin intake significantly reduced sleep blood pressure in male patients with untreated uncomplicated essential hypertension."

      "Melatonin taken at night could thus be a gentle alternative or supplement to regular antihypertensive medication," they propose.

      Hypertension 2004 Feb;43:2:192-7. Epub 2004 Jan 19. "Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send